The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global IgG4 Antibody Market Research Report 2025

Global IgG4 Antibody Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1897613

No of Pages : 102

Ask Your Query
Synopsis
IgG4 Antibody is a subclass of the IgG antibody, one of the major classes of antibodies produced by the immune system. IgG4 antibodies are involved in immune responses by recognizing and neutralizing foreign substances such as bacteria and viruses. This subclass of IgG antibodies is known for its lower affinity for antigens compared to other IgG subclasses, which allows for broader reactivity. IgG4 are commonly used in research and diagnostic applications to study immune responses and detect the presence of certain diseases, including autoimmune diseases and cancer.
The global IgG4 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for IgG4 Antibody has seen a rise due to its importance in immunology research and diagnostics. These antibodies have specific applications in the detection and characterization of certain diseases and conditions. The potential for IgG4 Antibody in targeted therapeutics and precision medicine is expected to drive the industry trend forward. As the field of immunology continues to advance, the use of IgG4 Antibody in research and potential clinical applications is likely to remain strong.
This report aims to provide a comprehensive presentation of the global market for IgG4 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IgG4 Antibody.
Report Scope
The IgG4 Antibody market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IgG4 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IgG4 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio X Cell
SouthernBiotech
MyBioSource
BosterBio
Biorbyt
BioLegend
Novus Biologicals
Sino Biological
RevMAb Biosciences
RayBiotech
ichorbio
Absolute Antibody
AntibodySystem
Thermo Fisher Scientific
Affinity Immuno
Dianova
Southern Biotech
Leinco Technologies
Abnova Corporation
Kyinno
Cell Sciences
ProSci
Bio-Rad
United States Biological
DIMA Biotechnology
OriGene Technologies
Abeomics
Cayman Chemical
R&D Systems
Biomatik
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IgG4 Antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IgG4 Antibody Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global IgG4 Antibody Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IgG4 Antibody Market Perspective (2019-2030)
2.2 IgG4 Antibody Growth Trends by Region
2.2.1 Global IgG4 Antibody Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 IgG4 Antibody Historic Market Size by Region (2019-2024)
2.2.3 IgG4 Antibody Forecasted Market Size by Region (2025-2030)
2.3 IgG4 Antibody Market Dynamics
2.3.1 IgG4 Antibody Industry Trends
2.3.2 IgG4 Antibody Market Drivers
2.3.3 IgG4 Antibody Market Challenges
2.3.4 IgG4 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IgG4 Antibody Players by Revenue
3.1.1 Global Top IgG4 Antibody Players by Revenue (2019-2024)
3.1.2 Global IgG4 Antibody Revenue Market Share by Players (2019-2024)
3.2 Global IgG4 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IgG4 Antibody Revenue
3.4 Global IgG4 Antibody Market Concentration Ratio
3.4.1 Global IgG4 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IgG4 Antibody Revenue in 2023
3.5 IgG4 Antibody Key Players Head office and Area Served
3.6 Key Players IgG4 Antibody Product Solution and Service
3.7 Date of Enter into IgG4 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IgG4 Antibody Breakdown Data by Type
4.1 Global IgG4 Antibody Historic Market Size by Type (2019-2024)
4.2 Global IgG4 Antibody Forecasted Market Size by Type (2025-2030)
5 IgG4 Antibody Breakdown Data by Application
5.1 Global IgG4 Antibody Historic Market Size by Application (2019-2024)
5.2 Global IgG4 Antibody Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America IgG4 Antibody Market Size (2019-2030)
6.2 North America IgG4 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America IgG4 Antibody Market Size by Country (2019-2024)
6.4 North America IgG4 Antibody Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IgG4 Antibody Market Size (2019-2030)
7.2 Europe IgG4 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe IgG4 Antibody Market Size by Country (2019-2024)
7.4 Europe IgG4 Antibody Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IgG4 Antibody Market Size (2019-2030)
8.2 Asia-Pacific IgG4 Antibody Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific IgG4 Antibody Market Size by Region (2019-2024)
8.4 Asia-Pacific IgG4 Antibody Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IgG4 Antibody Market Size (2019-2030)
9.2 Latin America IgG4 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America IgG4 Antibody Market Size by Country (2019-2024)
9.4 Latin America IgG4 Antibody Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IgG4 Antibody Market Size (2019-2030)
10.2 Middle East & Africa IgG4 Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa IgG4 Antibody Market Size by Country (2019-2024)
10.4 Middle East & Africa IgG4 Antibody Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio X Cell
11.1.1 Bio X Cell Company Detail
11.1.2 Bio X Cell Business Overview
11.1.3 Bio X Cell IgG4 Antibody Introduction
11.1.4 Bio X Cell Revenue in IgG4 Antibody Business (2019-2024)
11.1.5 Bio X Cell Recent Development
11.2 SouthernBiotech
11.2.1 SouthernBiotech Company Detail
11.2.2 SouthernBiotech Business Overview
11.2.3 SouthernBiotech IgG4 Antibody Introduction
11.2.4 SouthernBiotech Revenue in IgG4 Antibody Business (2019-2024)
11.2.5 SouthernBiotech Recent Development
11.3 MyBioSource
11.3.1 MyBioSource Company Detail
11.3.2 MyBioSource Business Overview
11.3.3 MyBioSource IgG4 Antibody Introduction
11.3.4 MyBioSource Revenue in IgG4 Antibody Business (2019-2024)
11.3.5 MyBioSource Recent Development
11.4 BosterBio
11.4.1 BosterBio Company Detail
11.4.2 BosterBio Business Overview
11.4.3 BosterBio IgG4 Antibody Introduction
11.4.4 BosterBio Revenue in IgG4 Antibody Business (2019-2024)
11.4.5 BosterBio Recent Development
11.5 Biorbyt
11.5.1 Biorbyt Company Detail
11.5.2 Biorbyt Business Overview
11.5.3 Biorbyt IgG4 Antibody Introduction
11.5.4 Biorbyt Revenue in IgG4 Antibody Business (2019-2024)
11.5.5 Biorbyt Recent Development
11.6 BioLegend
11.6.1 BioLegend Company Detail
11.6.2 BioLegend Business Overview
11.6.3 BioLegend IgG4 Antibody Introduction
11.6.4 BioLegend Revenue in IgG4 Antibody Business (2019-2024)
11.6.5 BioLegend Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Detail
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals IgG4 Antibody Introduction
11.7.4 Novus Biologicals Revenue in IgG4 Antibody Business (2019-2024)
11.7.5 Novus Biologicals Recent Development
11.8 Sino Biological
11.8.1 Sino Biological Company Detail
11.8.2 Sino Biological Business Overview
11.8.3 Sino Biological IgG4 Antibody Introduction
11.8.4 Sino Biological Revenue in IgG4 Antibody Business (2019-2024)
11.8.5 Sino Biological Recent Development
11.9 RevMAb Biosciences
11.9.1 RevMAb Biosciences Company Detail
11.9.2 RevMAb Biosciences Business Overview
11.9.3 RevMAb Biosciences IgG4 Antibody Introduction
11.9.4 RevMAb Biosciences Revenue in IgG4 Antibody Business (2019-2024)
11.9.5 RevMAb Biosciences Recent Development
11.10 RayBiotech
11.10.1 RayBiotech Company Detail
11.10.2 RayBiotech Business Overview
11.10.3 RayBiotech IgG4 Antibody Introduction
11.10.4 RayBiotech Revenue in IgG4 Antibody Business (2019-2024)
11.10.5 RayBiotech Recent Development
11.11 ichorbio
11.11.1 ichorbio Company Detail
11.11.2 ichorbio Business Overview
11.11.3 ichorbio IgG4 Antibody Introduction
11.11.4 ichorbio Revenue in IgG4 Antibody Business (2019-2024)
11.11.5 ichorbio Recent Development
11.12 Absolute Antibody
11.12.1 Absolute Antibody Company Detail
11.12.2 Absolute Antibody Business Overview
11.12.3 Absolute Antibody IgG4 Antibody Introduction
11.12.4 Absolute Antibody Revenue in IgG4 Antibody Business (2019-2024)
11.12.5 Absolute Antibody Recent Development
11.13 AntibodySystem
11.13.1 AntibodySystem Company Detail
11.13.2 AntibodySystem Business Overview
11.13.3 AntibodySystem IgG4 Antibody Introduction
11.13.4 AntibodySystem Revenue in IgG4 Antibody Business (2019-2024)
11.13.5 AntibodySystem Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Detail
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific IgG4 Antibody Introduction
11.14.4 Thermo Fisher Scientific Revenue in IgG4 Antibody Business (2019-2024)
11.14.5 Thermo Fisher Scientific Recent Development
11.15 Affinity Immuno
11.15.1 Affinity Immuno Company Detail
11.15.2 Affinity Immuno Business Overview
11.15.3 Affinity Immuno IgG4 Antibody Introduction
11.15.4 Affinity Immuno Revenue in IgG4 Antibody Business (2019-2024)
11.15.5 Affinity Immuno Recent Development
11.16 Dianova
11.16.1 Dianova Company Detail
11.16.2 Dianova Business Overview
11.16.3 Dianova IgG4 Antibody Introduction
11.16.4 Dianova Revenue in IgG4 Antibody Business (2019-2024)
11.16.5 Dianova Recent Development
11.17 Southern Biotech
11.17.1 Southern Biotech Company Detail
11.17.2 Southern Biotech Business Overview
11.17.3 Southern Biotech IgG4 Antibody Introduction
11.17.4 Southern Biotech Revenue in IgG4 Antibody Business (2019-2024)
11.17.5 Southern Biotech Recent Development
11.18 Leinco Technologies
11.18.1 Leinco Technologies Company Detail
11.18.2 Leinco Technologies Business Overview
11.18.3 Leinco Technologies IgG4 Antibody Introduction
11.18.4 Leinco Technologies Revenue in IgG4 Antibody Business (2019-2024)
11.18.5 Leinco Technologies Recent Development
11.19 Abnova Corporation
11.19.1 Abnova Corporation Company Detail
11.19.2 Abnova Corporation Business Overview
11.19.3 Abnova Corporation IgG4 Antibody Introduction
11.19.4 Abnova Corporation Revenue in IgG4 Antibody Business (2019-2024)
11.19.5 Abnova Corporation Recent Development
11.20 Kyinno
11.20.1 Kyinno Company Detail
11.20.2 Kyinno Business Overview
11.20.3 Kyinno IgG4 Antibody Introduction
11.20.4 Kyinno Revenue in IgG4 Antibody Business (2019-2024)
11.20.5 Kyinno Recent Development
11.21 Cell Sciences
11.21.1 Cell Sciences Company Detail
11.21.2 Cell Sciences Business Overview
11.21.3 Cell Sciences IgG4 Antibody Introduction
11.21.4 Cell Sciences Revenue in IgG4 Antibody Business (2019-2024)
11.21.5 Cell Sciences Recent Development
11.22 ProSci
11.22.1 ProSci Company Detail
11.22.2 ProSci Business Overview
11.22.3 ProSci IgG4 Antibody Introduction
11.22.4 ProSci Revenue in IgG4 Antibody Business (2019-2024)
11.22.5 ProSci Recent Development
11.23 Bio-Rad
11.23.1 Bio-Rad Company Detail
11.23.2 Bio-Rad Business Overview
11.23.3 Bio-Rad IgG4 Antibody Introduction
11.23.4 Bio-Rad Revenue in IgG4 Antibody Business (2019-2024)
11.23.5 Bio-Rad Recent Development
11.24 United States Biological
11.24.1 United States Biological Company Detail
11.24.2 United States Biological Business Overview
11.24.3 United States Biological IgG4 Antibody Introduction
11.24.4 United States Biological Revenue in IgG4 Antibody Business (2019-2024)
11.24.5 United States Biological Recent Development
11.25 DIMA Biotechnology
11.25.1 DIMA Biotechnology Company Detail
11.25.2 DIMA Biotechnology Business Overview
11.25.3 DIMA Biotechnology IgG4 Antibody Introduction
11.25.4 DIMA Biotechnology Revenue in IgG4 Antibody Business (2019-2024)
11.25.5 DIMA Biotechnology Recent Development
11.26 OriGene Technologies
11.26.1 OriGene Technologies Company Detail
11.26.2 OriGene Technologies Business Overview
11.26.3 OriGene Technologies IgG4 Antibody Introduction
11.26.4 OriGene Technologies Revenue in IgG4 Antibody Business (2019-2024)
11.26.5 OriGene Technologies Recent Development
11.27 Abeomics
11.27.1 Abeomics Company Detail
11.27.2 Abeomics Business Overview
11.27.3 Abeomics IgG4 Antibody Introduction
11.27.4 Abeomics Revenue in IgG4 Antibody Business (2019-2024)
11.27.5 Abeomics Recent Development
11.28 Cayman Chemical
11.28.1 Cayman Chemical Company Detail
11.28.2 Cayman Chemical Business Overview
11.28.3 Cayman Chemical IgG4 Antibody Introduction
11.28.4 Cayman Chemical Revenue in IgG4 Antibody Business (2019-2024)
11.28.5 Cayman Chemical Recent Development
11.29 R&D Systems
11.29.1 R&D Systems Company Detail
11.29.2 R&D Systems Business Overview
11.29.3 R&D Systems IgG4 Antibody Introduction
11.29.4 R&D Systems Revenue in IgG4 Antibody Business (2019-2024)
11.29.5 R&D Systems Recent Development
11.30 Biomatik
11.30.1 Biomatik Company Detail
11.30.2 Biomatik Business Overview
11.30.3 Biomatik IgG4 Antibody Introduction
11.30.4 Biomatik Revenue in IgG4 Antibody Business (2019-2024)
11.30.5 Biomatik Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock